{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 13,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 0
      },
      "2": {
        "core": 1,
        "branch": 0
      },
      "3": {
        "core": 1,
        "branch": 2
      },
      "4": {
        "core": 1,
        "branch": 4
      },
      "5": {
        "core": 1,
        "branch": 2
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A1 → A3)",
        "prover9_expression": "(approved(clinical_trial, drug_x) -> submitted(paper, journal))",
        "natural": "Provided that the clinical trial for Drug X was approved, the paper was submitted to a journal."
      },
      {
        "id": "Rule2",
        "formal": "(A10 → A9)",
        "prover9_expression": "(received(funding, grant_b) -> accepted(paper, journal))",
        "natural": "Whenever funding is received from Grant B, the paper is accepted by the journal."
      },
      {
        "id": "Rule3",
        "formal": "(A11 → G)",
        "prover9_expression": "(positive(results, drug_x) -> successful(project, outcome))",
        "natural": "In the event that the results for Drug X are positive, the project has a successful outcome."
      },
      {
        "id": "Rule4",
        "formal": "(A11 ∨ A12)",
        "prover9_expression": "(positive(results, drug_x) | negative(results, drug_x))",
        "natural": "The results for Drug X are either positive or negative."
      },
      {
        "id": "Rule5",
        "formal": "(A15 → A14)",
        "prover9_expression": "(marketed(drug_x, company) -> approved(drug_x, fda))",
        "natural": "If Drug X is marketed by a company, then it is approved by the FDA."
      },
      {
        "id": "Rule6",
        "formal": "(A16 → (¬(¬(A12 → G) → A13) → A15))",
        "prover9_expression": "(effective(drug_x, condition_y) -> (-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> marketed(drug_x, company)))",
        "natural": "If Drug X is effective for Condition Y, and if it is not the case that negative results for Drug X do not lead to a successful project outcome, which implies inconclusive results for Drug X, then Drug X is marketed by a company."
      },
      {
        "id": "Rule7",
        "formal": "(A18 → A19)",
        "prover9_expression": "(controversial(findings, ethics_board) -> accepted(findings, community))",
        "natural": "Provided that the findings are controversial with the ethics board, they are accepted by the community."
      },
      {
        "id": "Rule8",
        "formal": "(A18 ∨ G)",
        "prover9_expression": "(controversial(findings, ethics_board) | successful(project, outcome))",
        "natural": "The findings are controversial with the ethics board, or the project has a successful outcome."
      },
      {
        "id": "Rule9",
        "formal": "(A22 → (¬(A20 → ¬A19) → A21))",
        "prover9_expression": "(cited(paper, other_studies) -> (-(contradicts(study, previous_research) -> -accepted(findings, community)) -> requires(replication, study)))",
        "natural": "If the paper is cited by other studies, and if the study contradicting previous research does not imply that the findings are not accepted by the community, then replication of the study is required."
      },
      {
        "id": "Rule10",
        "formal": "(A23 → A22)",
        "prover9_expression": "(influential(paper, field) -> cited(paper, other_studies))",
        "natural": "Given that the paper is influential in the field, it is cited by other studies."
      },
      {
        "id": "Rule11",
        "formal": "(A23 ∨ A24)",
        "prover9_expression": "(influential(paper, field) | significant(paper, impact))",
        "natural": "Either the paper is influential in the field, or it has significant impact."
      },
      {
        "id": "Rule12",
        "formal": "(A24 → A22)",
        "prover9_expression": "(significant(paper, impact) -> cited(paper, other_studies))",
        "natural": "If the paper has significant impact, then it is cited by other studies."
      },
      {
        "id": "Rule13",
        "formal": "(A26 → (¬G → A25))",
        "prover9_expression": "(patented(drug_x, company) -> (-successful(project, outcome) -> rejected(drug_x, fda)))",
        "natural": "In the event that Drug X is patented by a company, and the project is not successful, then Drug X is rejected by the FDA."
      },
      {
        "id": "Rule14",
        "formal": "(A27 → A26)",
        "prover9_expression": "(discovered(compound, researcher) -> patented(drug_x, company))",
        "natural": "Whenever the compound is discovered by a researcher, Drug X is patented by a company."
      },
      {
        "id": "Rule15",
        "formal": "(A29 → A30)",
        "prover9_expression": "(safe(compound, humans) -> tested(compound, animals))",
        "natural": "Under the condition that the compound is safe for humans, it is tested on animals."
      },
      {
        "id": "Rule16",
        "formal": "(A30 → ¬A28)",
        "prover9_expression": "(tested(compound, animals) -> -toxic(compound, humans))",
        "natural": "If the compound is tested on animals, then it is not toxic to humans."
      },
      {
        "id": "Rule17",
        "formal": "(A31 → A32)",
        "prover9_expression": "(licensed(technology, university) -> commercialized(technology, startup))",
        "natural": "Whenever the technology is licensed by a university, it is commercialized by a startup."
      },
      {
        "id": "Rule18",
        "formal": "(A33 ∨ ¬A32)",
        "prover9_expression": "(profitable(technology, market) | -commercialized(technology, startup))",
        "natural": "The technology is profitable in the market, or it is not commercialized by a startup."
      },
      {
        "id": "Rule19",
        "formal": "(A34 → ¬A33)",
        "prover9_expression": "(failed(technology, market) -> -profitable(technology, market))",
        "natural": "In the case that the technology failed in the market, it is not profitable in the market."
      },
      {
        "id": "Rule20",
        "formal": "(A35 → A14)",
        "prover9_expression": "(approved_for_trial(drug_x, ethics_board) -> approved(drug_x, fda))",
        "natural": "If Drug X is approved for trial by the ethics board, then it is approved by the FDA."
      },
      {
        "id": "Rule21",
        "formal": "(A36 → A35)",
        "prover9_expression": "(enrolled(patients, trial) -> approved_for_trial(drug_x, ethics_board))",
        "natural": "Provided that patients are enrolled in the trial, Drug X is approved for trial by the ethics board."
      },
      {
        "id": "Rule22",
        "formal": "(A37 → (¬(¬(A12 → G) → A13) → A36))",
        "prover9_expression": "(recruited(patients, hospital_a) -> (-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> enrolled(patients, trial)))",
        "natural": "If patients are recruited from Hospital A, and if negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, then patients are enrolled in the trial."
      },
      {
        "id": "Rule23",
        "formal": "(A37 ∨ A38)",
        "prover9_expression": "(recruited(patients, hospital_a) | recruited(patients, hospital_b))",
        "natural": "Patients are recruited from Hospital A, or they are recruited from Hospital B."
      },
      {
        "id": "Rule24",
        "formal": "(A38 → (¬(¬(A12 → G) → A13) → A36))",
        "prover9_expression": "(recruited(patients, hospital_b) -> (-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> enrolled(patients, trial)))",
        "natural": "In the event that patients are recruited from Hospital B, and negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, then patients are enrolled in the trial."
      },
      {
        "id": "Rule25",
        "formal": "(A39 → A40)",
        "prover9_expression": "(referenced(paper, textbook) -> included(paper, meta_analysis))",
        "natural": "If the paper is referenced in a textbook, then it is included in a meta-analysis."
      },
      {
        "id": "Rule26",
        "formal": "(A4 → (A3 → A2))",
        "prover9_expression": "(requires(publication, peer_review) -> (submitted(paper, journal) -> published(results, journal)))",
        "natural": "Whenever publication requires peer review, and the paper is submitted to a journal, then the results are published in a journal."
      },
      {
        "id": "Rule27",
        "formal": "(A41 → (A40 → A22))",
        "prover9_expression": "(authored(paper, lead_scientist) -> (included(paper, meta_analysis) -> cited(paper, other_studies)))",
        "natural": "If the paper is authored by the lead scientist, and it is included in a meta-analysis, then it is cited by other studies."
      },
      {
        "id": "Rule28",
        "formal": "(A41 ∨ A42)",
        "prover9_expression": "(authored(paper, lead_scientist) | authored(paper, team))",
        "natural": "The paper is authored by the lead scientist, or it is authored by the team."
      },
      {
        "id": "Rule29",
        "formal": "(A42 → (A40 → A22))",
        "prover9_expression": "(authored(paper, team) -> (included(paper, meta_analysis) -> cited(paper, other_studies)))",
        "natural": "In the case that the paper is authored by the team, and it is included in a meta-analysis, then it is cited by other studies."
      },
      {
        "id": "Rule30",
        "formal": "(A44 ∨ (A43 ∨ (A20 → ¬A19)))",
        "prover9_expression": "(retracted(paper, journal) | (disputed(conclusions, experts) | (contradicts(study, previous_research) -> -accepted(findings, community))))",
        "natural": "The paper is retracted by the journal, or the conclusions are disputed by experts, or if the study contradicts previous research, then the findings are not accepted by the community."
      },
      {
        "id": "Rule31",
        "formal": "(A45 → ¬A19)",
        "prover9_expression": "(flawed(methodology, study) -> -accepted(findings, community))",
        "natural": "If the methodology of the study is flawed, then the findings are not accepted by the community."
      },
      {
        "id": "Rule32",
        "formal": "(A46 ∨ A45)",
        "prover9_expression": "(valid(methodology, study) | flawed(methodology, study))",
        "natural": "The methodology of the study is either valid or flawed."
      },
      {
        "id": "Rule33",
        "formal": "(A47 → ¬A46)",
        "prover9_expression": "(verified(results, independent_lab) -> -valid(methodology, study))",
        "natural": "Provided that the results are verified by an independent lab, the methodology of the study is not valid."
      },
      {
        "id": "Rule34",
        "formal": "(A48 → A47)",
        "prover9_expression": "(confirmed(results, replication_study) -> verified(results, independent_lab))",
        "natural": "Under the condition that the results are confirmed by a replication study, they are verified by an independent lab."
      },
      {
        "id": "Rule35",
        "formal": "(A49 → A22)",
        "prover9_expression": "(featured(paper, conference) -> cited(paper, other_studies))",
        "natural": "If the paper is featured at a conference, then it is cited by other studies."
      },
      {
        "id": "Rule36",
        "formal": "(A5 → A6)",
        "prover9_expression": "(funded(study, grant_a) -> conducted(research, university))",
        "natural": "Whenever the study is funded by Grant A, the research is conducted at a university."
      },
      {
        "id": "Rule37",
        "formal": "(A50 → A49)",
        "prover9_expression": "(created(artwork, science_illustrator) -> featured(paper, conference))",
        "natural": "If the artwork is created by a science illustrator, then the paper is featured at a conference."
      },
      {
        "id": "Rule38",
        "formal": "(A52 → A53)",
        "prover9_expression": "(sold(artwork, collector) -> displayed(artwork, museum))",
        "natural": "Provided that the artwork is sold to a collector, it is displayed in a museum."
      },
      {
        "id": "Rule39",
        "formal": "(A54 → A26)",
        "prover9_expression": "(developed(formulation, chemist) -> patented(drug_x, company))",
        "natural": "Under the condition that the formulation is developed by a chemist, Drug X is patented by a company."
      },
      {
        "id": "Rule40",
        "formal": "(A57 → A56)",
        "prover9_expression": "(purified(compound, process) -> synthesized(compound, lab))",
        "natural": "If the compound is purified through a process, then it is synthesized in a lab."
      },
      {
        "id": "Rule41",
        "formal": "(A58 → (¬A27 → A57))",
        "prover9_expression": "(optimized(synthesis, method) -> (-discovered(compound, researcher) -> purified(compound, process)))",
        "natural": "Whenever the synthesis is optimized by a method, and the compound is not discovered by a researcher, then the compound is purified through a process."
      },
      {
        "id": "Rule42",
        "formal": "(A6 → A7)",
        "prover9_expression": "(conducted(research, university) -> analyzed(data, statistician))",
        "natural": "Given that the research is conducted at a university, the data are analyzed by a statistician."
      },
      {
        "id": "Rule43",
        "formal": "(A61 → (A60 → A59))",
        "prover9_expression": "(documented(procedure, lab_notebook) -> (improved(yield, process) -> scaled_up(production, facility)))",
        "natural": "Provided that the procedure is documented in a lab notebook, and the yield is improved by the process, then production is scaled up at a facility."
      },
      {
        "id": "Rule44",
        "formal": "(A62 → (A60 → A59))",
        "prover9_expression": "(documented(procedure, electronic_records) -> (improved(yield, process) -> scaled_up(production, facility)))",
        "natural": "If the procedure is documented in electronic records, and the yield is improved by the process, then production is scaled up at a facility."
      },
      {
        "id": "Rule45",
        "formal": "(A63 → (A61 ∨ A62))",
        "prover9_expression": "(standardized(protocol, lab) -> (documented(procedure, lab_notebook) | documented(procedure, electronic_records)))",
        "natural": "Whenever the protocol is standardized in the lab, the procedure is documented in a lab notebook or in electronic records."
      },
      {
        "id": "Rule46",
        "formal": "(A63 ∨ A64)",
        "prover9_expression": "(standardized(protocol, lab) | validated(protocol, quality_control))",
        "natural": "The protocol is standardized in the lab, or it is validated by quality control."
      },
      {
        "id": "Rule47",
        "formal": "(A64 → (A61 ∨ A62))",
        "prover9_expression": "(validated(protocol, quality_control) -> (documented(procedure, lab_notebook) | documented(procedure, electronic_records)))",
        "natural": "Under the condition that the protocol is validated by quality control, the procedure is documented in a lab notebook or in electronic records."
      },
      {
        "id": "Rule48",
        "formal": "(A7 → A8)",
        "prover9_expression": "(analyzed(data, statistician) -> completed(study, timeline))",
        "natural": "If the data are analyzed by a statistician, then the study is completed within the timeline."
      },
      {
        "id": "Rule49",
        "formal": "(A8 → A10)",
        "prover9_expression": "(completed(study, timeline) -> received(funding, grant_b))",
        "natural": "In the event that the study is completed within the timeline, funding is received from Grant B."
      },
      {
        "id": "Rule50",
        "formal": "(A9 → G)",
        "prover9_expression": "(accepted(paper, journal) -> successful(project, outcome))",
        "natural": "Given that the paper is accepted by the journal, the project has a successful outcome."
      },
      {
        "id": "Rule51",
        "formal": "(¬(A12 → G) → ¬A13)",
        "prover9_expression": "(-(negative(results, drug_x) -> successful(project, outcome)) -> -inconclusive(results, drug_x))",
        "natural": "Provided that negative results for Drug X do not lead to a successful project outcome, the results for Drug X are not inconclusive."
      },
      {
        "id": "Rule52",
        "formal": "(¬(A20 → ¬A19) → ¬A21)",
        "prover9_expression": "(-(contradicts(study, previous_research) -> -accepted(findings, community)) -> -requires(replication, study))",
        "natural": "If the study contradicting previous research does not imply that the findings are not accepted by the community, then replication of the study is not required."
      },
      {
        "id": "Rule53",
        "formal": "(¬(¬(A12 → G) → A13) → A31)",
        "prover9_expression": "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> licensed(technology, university))",
        "natural": "Provided that negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, the technology is licensed by a university."
      },
      {
        "id": "Rule54",
        "formal": "(¬(¬(A12 → G) → A13) → ¬A14)",
        "prover9_expression": "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> -approved(drug_x, fda))",
        "natural": "In the event that negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, Drug X is not approved by the FDA."
      },
      {
        "id": "Rule55",
        "formal": "(¬(¬A50 → A51) → A52)",
        "prover9_expression": "(-(-created(artwork, science_illustrator) -> exhibited(artwork, gallery)) -> sold(artwork, collector))",
        "natural": "If it is not the case that the artwork not being created by a science illustrator implies it is exhibited in a gallery, then the artwork is sold to a collector."
      },
      {
        "id": "Rule56",
        "formal": "(¬A16 → A17)",
        "prover9_expression": "(-effective(drug_x, condition_y) -> ineffective(drug_x, condition_y))",
        "natural": "Whenever Drug X is not effective for Condition Y, it is ineffective for Condition Y."
      },
      {
        "id": "Rule57",
        "formal": "(¬A16 → ¬A17)",
        "prover9_expression": "(-effective(drug_x, condition_y) -> -ineffective(drug_x, condition_y))",
        "natural": "Provided that Drug X is not effective for Condition Y, it is not ineffective for Condition Y."
      },
      {
        "id": "Rule58",
        "formal": "(¬A27 → A28)",
        "prover9_expression": "(-discovered(compound, researcher) -> toxic(compound, humans))",
        "natural": "Under the condition that the compound is not discovered by a researcher, it is toxic to humans."
      },
      {
        "id": "Rule59",
        "formal": "(¬A27 → A29)",
        "prover9_expression": "(-discovered(compound, researcher) -> safe(compound, humans))",
        "natural": "If the compound is not discovered by a researcher, then it is safe for humans."
      },
      {
        "id": "Rule60",
        "formal": "(¬A27 → ¬A56)",
        "prover9_expression": "(-discovered(compound, researcher) -> -synthesized(compound, lab))",
        "natural": "If the compound is not discovered by a researcher, then it is not synthesized in a lab."
      },
      {
        "id": "Rule61",
        "formal": "(¬A54 → A55)",
        "prover9_expression": "(-developed(formulation, chemist) -> abandoned(formulation, project))",
        "natural": "Under the condition that the formulation is not developed by a chemist, it is abandoned by the project."
      },
      {
        "id": "Rule62",
        "formal": "(¬A58 → A60)",
        "prover9_expression": "(-optimized(synthesis, method) -> improved(yield, process))",
        "natural": "Provided that the synthesis is not optimized by a method, the yield is improved by the process."
      },
      {
        "id": "Rule63",
        "formal": "(¬G → A1)",
        "prover9_expression": "(-successful(project, outcome) -> approved(clinical_trial, drug_x))",
        "natural": "If the project is not successful, then the clinical trial for Drug X is approved."
      },
      {
        "id": "Rule64",
        "formal": "(¬G → ¬A25)",
        "prover9_expression": "(-successful(project, outcome) -> -rejected(drug_x, fda))",
        "natural": "Under the condition that the project is not successful, Drug X is not rejected by the FDA."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A20",
        "prover9_expression": "contradicts(study, previous_research)",
        "natural": "The study contradicts previous research."
      },
      {
        "id": "Fact2",
        "formal": "A34",
        "prover9_expression": "failed(technology, market)",
        "natural": "The technology failed in the market."
      },
      {
        "id": "Fact3",
        "formal": "A39",
        "prover9_expression": "referenced(paper, textbook)",
        "natural": "The paper is referenced in a textbook."
      },
      {
        "id": "Fact4",
        "formal": "A4",
        "prover9_expression": "requires(publication, peer_review)",
        "natural": "Publication requires peer review."
      },
      {
        "id": "Fact5",
        "formal": "A48",
        "prover9_expression": "confirmed(results, replication_study)",
        "natural": "The results were confirmed by a replication study."
      },
      {
        "id": "Fact6",
        "formal": "A5",
        "prover9_expression": "funded(study, grant_a)",
        "natural": "The study was funded by Grant A."
      },
      {
        "id": "Fact7",
        "formal": "¬A2",
        "prover9_expression": "-published(results, journal)",
        "natural": "The results were not published in a journal."
      },
      {
        "id": "Fact8",
        "formal": "¬A43",
        "prover9_expression": "-disputed(conclusions, experts)",
        "natural": "The conclusions are not disputed by experts."
      },
      {
        "id": "Fact9",
        "formal": "¬A44",
        "prover9_expression": "-retracted(paper, journal)",
        "natural": "The paper is not retracted by the journal."
      },
      {
        "id": "Fact10",
        "formal": "¬A51",
        "prover9_expression": "-exhibited(artwork, gallery)",
        "natural": "The artwork is not exhibited in a gallery."
      },
      {
        "id": "Fact11",
        "formal": "¬A53",
        "prover9_expression": "-displayed(artwork, museum)",
        "natural": "The artwork is not displayed in a museum."
      },
      {
        "id": "Fact12",
        "formal": "¬A55",
        "prover9_expression": "-abandoned(formulation, project)",
        "natural": "The formulation is not abandoned by the project."
      },
      {
        "id": "Fact13",
        "formal": "¬A59",
        "prover9_expression": "-scaled_up(production, facility)",
        "natural": "Production is not scaled up at a facility."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "successful(project, outcome)",
    "natural": "The project had a successful outcome."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A4 -> (A3 -> A2))",
            "A4"
          ],
          "conclusion": "(A3 -> A2)",
          "natural": "Provided that the paper is submitted to a journal, the results are published in a journal."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A1 -> A3)",
            "(A3 -> A2)"
          ],
          "conclusion": "(A1 -> A2)",
          "natural": "If the clinical trial for Drug X was approved, then the results were published in a journal."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(A1 -> A2)",
            "-A2"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that the clinical trial for Drug X was approved."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A1)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "The project had a successful outcome."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A8 -> A10)",
            "(A10 -> A9)"
          ],
          "conclusion": "(A8 -> A9)",
          "natural": "Whenever the study is completed within the timeline, the paper is accepted by the journal."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A8 -> A9)",
            "(A9 -> G)"
          ],
          "conclusion": "(A8 -> G)",
          "natural": "If the study is completed within the timeline, then the project has a successful outcome."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(A7 -> A8)",
            "(A8 -> G)"
          ],
          "conclusion": "(A7 -> G)",
          "natural": "Provided that the data are analyzed by a statistician, the project has a successful outcome."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(A6 -> A7)",
            "(A7 -> G)"
          ],
          "conclusion": "(A6 -> G)",
          "natural": "If the research is conducted at a university, then the project has a successful outcome."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            "(A5 -> A6)",
            "(A6 -> G)"
          ],
          "conclusion": "(A5 -> G)",
          "natural": "In the event that the study is funded by Grant A, the project has a successful outcome."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A5 -> G)",
            "A5"
          ],
          "conclusion": "G",
          "natural": "The project had a successful outcome."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A16 -> A17)",
            "(-A16 -> -A17)"
          ],
          "conclusion": "A16",
          "natural": "Drug X is effective for Condition Y."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A16 -> (-(-(A12 -> G) -> A13) -> A15))",
            "A16"
          ],
          "conclusion": "(-(-(A12 -> G) -> A13) -> A15)",
          "natural": "Whenever negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, Drug X is marketed by a company."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(A12 -> G) -> A13) -> A15)",
            "(A15 -> A14)"
          ],
          "conclusion": "(-(-(A12 -> G) -> A13) -> A14)",
          "natural": "In the case that negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, then Drug X is approved by the FDA."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(A12 -> G) -> A13) -> A14)",
            "(-(-(A12 -> G) -> A13) -> -A14)"
          ],
          "conclusion": "(-(A12 -> G) -> A13)",
          "natural": "If negative results for Drug X do not lead to a successful project outcome, then the results for Drug X are inconclusive."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A12 -> G) -> A13)",
            "(-(A12 -> G) -> -A13)"
          ],
          "conclusion": "(A12 -> G)",
          "natural": "Under the condition that the results for Drug X are negative, the project has a successful outcome."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A11 | A12)",
            "(A11 -> G)",
            "(A12 -> G)"
          ],
          "conclusion": "G",
          "natural": "The project had a successful outcome."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 4,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A23 | A24)",
            "(A23 -> A22)",
            "(A24 -> A22)"
          ],
          "conclusion": "A22",
          "natural": "The paper is cited by other studies."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A22 -> (-(A20 -> -A19) -> A21))",
            "A22"
          ],
          "conclusion": "(-(A20 -> -A19) -> A21)",
          "natural": "Under the condition that the study contradicting previous research does not imply that the findings are not accepted by the community, replication of the study is required."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A20 -> -A19) -> A21)",
            "(-(A20 -> -A19) -> -A21)"
          ],
          "conclusion": "(A20 -> -A19)",
          "natural": "Whenever the study contradicts previous research, it is not the case that the findings are accepted by the community."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A20 -> -A19)",
            "A20"
          ],
          "conclusion": "-A19",
          "natural": "The findings are not accepted by the community."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(A18 -> A19)",
            "-A19"
          ],
          "conclusion": "-A18",
          "natural": "The findings are not controversial with the ethics board."
        },
        {
          "step_number": 6,
          "rule_applied": "DS",
          "premises_used": [
            "(A18 | G)",
            "-A18"
          ],
          "conclusion": "G",
          "natural": "The project had a successful outcome."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 5,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A29 -> A30)",
            "(A30 -> -A28)"
          ],
          "conclusion": "(A29 -> -A28)",
          "natural": "If the compound is safe for humans, then it is not toxic to humans."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-A27 -> A29)",
            "(A29 -> -A28)"
          ],
          "conclusion": "(-A27 -> -A28)",
          "natural": "Whenever the compound is not discovered by a researcher, it is not toxic to humans."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A27 -> A28)",
            "(-A27 -> -A28)"
          ],
          "conclusion": "A27",
          "natural": "The compound is discovered by a researcher."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A27 -> A26)",
            "A27"
          ],
          "conclusion": "A26",
          "natural": "Drug X is patented by a company."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            "(A26 -> (-G -> A25))",
            "A26"
          ],
          "conclusion": "(-G -> A25)",
          "natural": "Whenever the project is not successful, Drug X is rejected by the FDA."
        },
        {
          "step_number": 6,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A25)",
            "(-G -> -A25)"
          ],
          "conclusion": "G",
          "natural": "The project had a successful outcome."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A34 -> -A33)",
            "A34"
          ],
          "conclusion": "-A33",
          "natural": "The technology is not profitable in the market."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A33 | -A32)",
            "-A33"
          ],
          "conclusion": "-A32",
          "natural": "The technology is not commercialized by a startup."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(A31 -> A32)",
            "-A32"
          ],
          "conclusion": "-A31",
          "natural": "The technology is not licensed by a university."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-(A12 -> G) -> A13) -> A31)",
            "-A31"
          ],
          "conclusion": "(-(A12 -> G) -> A13)",
          "natural": "If negative results for Drug X do not lead to a successful project outcome, then the results for Drug X are inconclusive."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A12 -> G) -> A13)",
            "(-(A12 -> G) -> -A13)"
          ],
          "conclusion": "(A12 -> G)",
          "natural": "Under the condition that the results for Drug X are negative, the project has a successful outcome."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A11 | A12)",
            "(A11 -> G)",
            "(A12 -> G)"
          ],
          "conclusion": "G",
          "natural": "The project had a successful outcome."
        }
      ]
    },
    {
      "id": 7,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A37 | A38)",
            "(A37 -> (-(-(A12 -> G) -> A13) -> A36))",
            "(A38 -> (-(-(A12 -> G) -> A13) -> A36))"
          ],
          "conclusion": "(-(-(A12 -> G) -> A13) -> A36)",
          "natural": "Under the condition that negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, patients are enrolled in the trial."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(A12 -> G) -> A13) -> A36)",
            "(A36 -> A35)"
          ],
          "conclusion": "(-(-(A12 -> G) -> A13) -> A35)",
          "natural": "If negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, then Drug X is approved for trial by the ethics board."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(A12 -> G) -> A13) -> A35)",
            "(A35 -> A14)"
          ],
          "conclusion": "(-(-(A12 -> G) -> A13) -> A14)",
          "natural": "In the case that negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, then Drug X is approved by the FDA."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(A12 -> G) -> A13) -> A14)",
            "(-(-(A12 -> G) -> A13) -> -A14)"
          ],
          "conclusion": "(-(A12 -> G) -> A13)",
          "natural": "If negative results for Drug X do not lead to a successful project outcome, then the results for Drug X are inconclusive."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A12 -> G) -> A13)",
            "(-(A12 -> G) -> -A13)"
          ],
          "conclusion": "(A12 -> G)",
          "natural": "Under the condition that the results for Drug X are negative, the project has a successful outcome."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A11 | A12)",
            "(A11 -> G)",
            "(A12 -> G)"
          ],
          "conclusion": "G",
          "natural": "The project had a successful outcome."
        }
      ]
    },
    {
      "id": 8,
      "family_id": 4,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A41 | A42)",
            "(A41 -> (A40 -> A22))",
            "(A42 -> (A40 -> A22))"
          ],
          "conclusion": "(A40 -> A22)",
          "natural": "Provided that the paper is included in a meta-analysis, it is cited by other studies."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A39 -> A40)",
            "(A40 -> A22)"
          ],
          "conclusion": "(A39 -> A22)",
          "natural": "Under the condition that the paper is referenced in a textbook, it is cited by other studies."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A39 -> A22)",
            "A39"
          ],
          "conclusion": "A22",
          "natural": "The paper is cited by other studies."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A22 -> (-(A20 -> -A19) -> A21))",
            "A22"
          ],
          "conclusion": "(-(A20 -> -A19) -> A21)",
          "natural": "Under the condition that the study contradicting previous research does not imply that the findings are not accepted by the community, replication of the study is required."
        },
        {
          "step_number": 5,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A20 -> -A19) -> A21)",
            "(-(A20 -> -A19) -> -A21)"
          ],
          "conclusion": "(A20 -> -A19)",
          "natural": "Whenever the study contradicts previous research, it is not the case that the findings are accepted by the community."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A20 -> -A19)",
            "A20"
          ],
          "conclusion": "-A19",
          "natural": "The findings are not accepted by the community."
        },
        {
          "step_number": 7,
          "rule_applied": "MT",
          "premises_used": [
            "(A18 -> A19)",
            "-A19"
          ],
          "conclusion": "-A18",
          "natural": "The findings are not controversial with the ethics board."
        },
        {
          "step_number": 8,
          "rule_applied": "DS",
          "premises_used": [
            "(A18 | G)",
            "-A18"
          ],
          "conclusion": "G",
          "natural": "The project had a successful outcome."
        }
      ]
    },
    {
      "id": 9,
      "family_id": 4,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A44 | (A43 | (A20 -> -A19)))",
            "-A44"
          ],
          "conclusion": "(A43 | (A20 -> -A19))",
          "natural": "The conclusions are disputed by experts, or if the study contradicts previous research, then the findings are not accepted by the community."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A43 | (A20 -> -A19))",
            "-A43"
          ],
          "conclusion": "(A20 -> -A19)",
          "natural": "Whenever the study contradicts previous research, it is not the case that the findings are accepted by the community."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A20 -> -A19)",
            "A20"
          ],
          "conclusion": "-A19",
          "natural": "The findings are not accepted by the community."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(A18 -> A19)",
            "-A19"
          ],
          "conclusion": "-A18",
          "natural": "The findings are not controversial with the ethics board."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A18 | G)",
            "-A18"
          ],
          "conclusion": "G",
          "natural": "The project had a successful outcome."
        }
      ]
    },
    {
      "id": 10,
      "family_id": 4,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A48 -> A47)",
            "A48"
          ],
          "conclusion": "A47",
          "natural": "The results were verified by an independent lab."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A47 -> -A46)",
            "A47"
          ],
          "conclusion": "-A46",
          "natural": "The methodology of the study is not valid."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A46 | A45)",
            "-A46"
          ],
          "conclusion": "A45",
          "natural": "The methodology of the study is flawed."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A45 -> -A19)",
            "A45"
          ],
          "conclusion": "-A19",
          "natural": "The findings are not accepted by the community."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(A18 -> A19)",
            "-A19"
          ],
          "conclusion": "-A18",
          "natural": "The findings are not controversial with the ethics board."
        },
        {
          "step_number": 6,
          "rule_applied": "DS",
          "premises_used": [
            "(A18 | G)",
            "-A18"
          ],
          "conclusion": "G",
          "natural": "The project had a successful outcome."
        }
      ]
    },
    {
      "id": 11,
      "family_id": 4,
      "path_type": "branch",
      "branch_from": 0,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(A52 -> A53)",
            "-A53"
          ],
          "conclusion": "-A52",
          "natural": "The artwork is not sold to a collector."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-A50 -> A51) -> A52)",
            "-A52"
          ],
          "conclusion": "(-A50 -> A51)",
          "natural": "Given that the artwork is not created by a science illustrator, it is exhibited in a gallery."
        },
        {
          "step_number": 3,
          "rule_applied": "MT",
          "premises_used": [
            "(-A50 -> A51)",
            "-A51"
          ],
          "conclusion": "A50",
          "natural": "The artwork was created by a science illustrator."
        },
        {
          "step_number": 4,
          "rule_applied": "MP",
          "premises_used": [
            "(A50 -> A49)",
            "A50"
          ],
          "conclusion": "A49",
          "natural": "The paper was featured at a conference."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            "(A49 -> A22)",
            "A49"
          ],
          "conclusion": "A22",
          "natural": "The paper is cited by other studies."
        },
        {
          "step_number": 6,
          "rule_applied": "MP",
          "premises_used": [
            "(A22 -> (-(A20 -> -A19) -> A21))",
            "A22"
          ],
          "conclusion": "(-(A20 -> -A19) -> A21)",
          "natural": "Under the condition that the study contradicting previous research does not imply that the findings are not accepted by the community, replication of the study is required."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A20 -> -A19) -> A21)",
            "(-(A20 -> -A19) -> -A21)"
          ],
          "conclusion": "(A20 -> -A19)",
          "natural": "Whenever the study contradicts previous research, it is not the case that the findings are accepted by the community."
        },
        {
          "step_number": 8,
          "rule_applied": "MP",
          "premises_used": [
            "(A20 -> -A19)",
            "A20"
          ],
          "conclusion": "-A19",
          "natural": "The findings are not accepted by the community."
        },
        {
          "step_number": 9,
          "rule_applied": "MT",
          "premises_used": [
            "(A18 -> A19)",
            "-A19"
          ],
          "conclusion": "-A18",
          "natural": "The findings are not controversial with the ethics board."
        },
        {
          "step_number": 10,
          "rule_applied": "DS",
          "premises_used": [
            "(A18 | G)",
            "-A18"
          ],
          "conclusion": "G",
          "natural": "The project had a successful outcome."
        }
      ]
    },
    {
      "id": 12,
      "family_id": 5,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(-A54 -> A55)",
            "-A55"
          ],
          "conclusion": "A54",
          "natural": "The formulation was developed by a chemist."
        },
        {
          "step_number": 2,
          "rule_applied": "MP",
          "premises_used": [
            "(A54 -> A26)",
            "A54"
          ],
          "conclusion": "A26",
          "natural": "Drug X is patented by a company."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A26 -> (-G -> A25))",
            "A26"
          ],
          "conclusion": "(-G -> A25)",
          "natural": "Whenever the project is not successful, Drug X is rejected by the FDA."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A25)",
            "(-G -> -A25)"
          ],
          "conclusion": "G",
          "natural": "The project had a successful outcome."
        }
      ]
    },
    {
      "id": 13,
      "family_id": 5,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DE",
          "premises_used": [
            "(A63 | A64)",
            "(A63 -> (A61 | A62))",
            "(A64 -> (A61 | A62))"
          ],
          "conclusion": "(A61 | A62)",
          "natural": "The procedure is documented in a lab notebook, or it is documented in electronic records."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A61 | A62)",
            "(A61 -> (A60 -> A59))",
            "(A62 -> (A60 -> A59))"
          ],
          "conclusion": "(A60 -> A59)",
          "natural": "In the case that the yield is improved by the process, production is scaled up at a facility."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(-A58 -> A60)",
            "(A60 -> A59)"
          ],
          "conclusion": "(-A58 -> A59)",
          "natural": "In the event that the synthesis is not optimized by a method, production is scaled up at a facility."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-A58 -> A59)",
            "-A59"
          ],
          "conclusion": "A58",
          "natural": "The synthesis was optimized by a method."
        },
        {
          "step_number": 5,
          "rule_applied": "MP",
          "premises_used": [
            "(A58 -> (-A27 -> A57))",
            "A58"
          ],
          "conclusion": "(-A27 -> A57)",
          "natural": "Provided that the compound is not discovered by a researcher, it is purified through a process."
        },
        {
          "step_number": 6,
          "rule_applied": "HS",
          "premises_used": [
            "(-A27 -> A57)",
            "(A57 -> A56)"
          ],
          "conclusion": "(-A27 -> A56)",
          "natural": "In the case that the compound is not discovered by a researcher, it is synthesized in a lab."
        },
        {
          "step_number": 7,
          "rule_applied": "RAA",
          "premises_used": [
            "(-A27 -> A56)",
            "(-A27 -> -A56)"
          ],
          "conclusion": "A27",
          "natural": "The compound is discovered by a researcher."
        },
        {
          "step_number": 8,
          "rule_applied": "MP",
          "premises_used": [
            "(A27 -> A26)",
            "A27"
          ],
          "conclusion": "A26",
          "natural": "Drug X is patented by a company."
        },
        {
          "step_number": 9,
          "rule_applied": "MP",
          "premises_used": [
            "(A26 -> (-G -> A25))",
            "A26"
          ],
          "conclusion": "(-G -> A25)",
          "natural": "Whenever the project is not successful, Drug X is rejected by the FDA."
        },
        {
          "step_number": 10,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A25)",
            "(-G -> -A25)"
          ],
          "conclusion": "G",
          "natural": "The project had a successful outcome."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Scientific Research",
    "atomic_facts": {
      "A1": "approved(clinical_trial, drug_x)",
      "A2": "published(results, journal)",
      "A3": "submitted(paper, journal)",
      "A4": "requires(publication, peer_review)",
      "A5": "funded(study, grant_a)",
      "A6": "conducted(research, university)",
      "A7": "analyzed(data, statistician)",
      "A8": "completed(study, timeline)",
      "A9": "accepted(paper, journal)",
      "A10": "received(funding, grant_b)",
      "A11": "positive(results, drug_x)",
      "A12": "negative(results, drug_x)",
      "A13": "inconclusive(results, drug_x)",
      "A14": "approved(drug_x, fda)",
      "A15": "marketed(drug_x, company)",
      "A16": "effective(drug_x, condition_y)",
      "A17": "ineffective(drug_x, condition_y)",
      "A18": "controversial(findings, ethics_board)",
      "A19": "accepted(findings, community)",
      "A20": "contradicts(study, previous_research)",
      "A21": "requires(replication, study)",
      "A22": "cited(paper, other_studies)",
      "A23": "influential(paper, field)",
      "A24": "significant(paper, impact)",
      "A25": "rejected(drug_x, fda)",
      "A26": "patented(drug_x, company)",
      "A27": "discovered(compound, researcher)",
      "A28": "toxic(compound, humans)",
      "A29": "safe(compound, humans)",
      "A30": "tested(compound, animals)",
      "A31": "licensed(technology, university)",
      "A32": "commercialized(technology, startup)",
      "A33": "profitable(technology, market)",
      "A34": "failed(technology, market)",
      "A35": "approved_for_trial(drug_x, ethics_board)",
      "A36": "enrolled(patients, trial)",
      "A37": "recruited(patients, hospital_a)",
      "A38": "recruited(patients, hospital_b)",
      "A39": "referenced(paper, textbook)",
      "A40": "included(paper, meta_analysis)",
      "A41": "authored(paper, lead_scientist)",
      "A42": "authored(paper, team)",
      "A43": "disputed(conclusions, experts)",
      "A44": "retracted(paper, journal)",
      "A45": "flawed(methodology, study)",
      "A46": "valid(methodology, study)",
      "A47": "verified(results, independent_lab)",
      "A48": "confirmed(results, replication_study)",
      "A49": "featured(paper, conference)",
      "A50": "created(artwork, science_illustrator)",
      "A51": "exhibited(artwork, gallery)",
      "A52": "sold(artwork, collector)",
      "A53": "displayed(artwork, museum)",
      "A54": "developed(formulation, chemist)",
      "A55": "abandoned(formulation, project)",
      "A56": "synthesized(compound, lab)",
      "A57": "purified(compound, process)",
      "A58": "optimized(synthesis, method)",
      "A59": "scaled_up(production, facility)",
      "A60": "improved(yield, process)",
      "A61": "documented(procedure, lab_notebook)",
      "A62": "documented(procedure, electronic_records)",
      "A63": "standardized(protocol, lab)",
      "A64": "validated(protocol, quality_control)",
      "G": "successful(project, outcome)"
    },
    "natural_facts": {
      "A1": "The clinical trial for Drug X was approved.",
      "A2": "The results were published in a journal.",
      "A3": "The paper was submitted to a journal.",
      "A4": "Publication requires peer review.",
      "A5": "The study was funded by Grant A.",
      "A6": "The research was conducted at a university.",
      "A7": "The data were analyzed by a statistician.",
      "A8": "The study was completed within the timeline.",
      "A9": "The paper was accepted by the journal.",
      "A10": "Funding was received from Grant B.",
      "A11": "The results for Drug X were positive.",
      "A12": "The results for Drug X were negative.",
      "A13": "The results for Drug X were inconclusive.",
      "A14": "Drug X was approved by the FDA.",
      "A15": "Drug X was marketed by a company.",
      "A16": "Drug X is effective for Condition Y.",
      "A17": "Drug X is ineffective for Condition Y.",
      "A18": "The findings were controversial with the ethics board.",
      "A19": "The findings were accepted by the community.",
      "A20": "The study contradicts previous research.",
      "A21": "Replication of the study is required.",
      "A22": "The paper was cited by other studies.",
      "A23": "The paper is influential in the field.",
      "A24": "The paper has significant impact.",
      "A25": "Drug X was rejected by the FDA.",
      "A26": "Drug X was patented by a company.",
      "A27": "The compound was discovered by a researcher.",
      "A28": "The compound is toxic to humans.",
      "A29": "The compound is safe for humans.",
      "A30": "The compound was tested on animals.",
      "A31": "The technology was licensed by a university.",
      "A32": "The technology was commercialized by a startup.",
      "A33": "The technology is profitable in the market.",
      "A34": "The technology failed in the market.",
      "A35": "Drug X was approved for trial by the ethics board.",
      "A36": "Patients were enrolled in the trial.",
      "A37": "Patients were recruited from Hospital A.",
      "A38": "Patients were recruited from Hospital B.",
      "A39": "The paper was referenced in a textbook.",
      "A40": "The paper was included in a meta-analysis.",
      "A41": "The paper was authored by the lead scientist.",
      "A42": "The paper was authored by the team.",
      "A43": "The conclusions are disputed by experts.",
      "A44": "The paper was retracted by the journal.",
      "A45": "The methodology of the study is flawed.",
      "A46": "The methodology of the study is valid.",
      "A47": "The results were verified by an independent lab.",
      "A48": "The results were confirmed by a replication study.",
      "A49": "The paper was featured at a conference.",
      "A50": "The artwork was created by a science illustrator.",
      "A51": "The artwork was exhibited in a gallery.",
      "A52": "The artwork was sold to a collector.",
      "A53": "The artwork was displayed in a museum.",
      "A54": "The formulation was developed by a chemist.",
      "A55": "The formulation was abandoned by the project.",
      "A56": "The compound was synthesized in a lab.",
      "A57": "The compound was purified through a process.",
      "A58": "The synthesis was optimized by a method.",
      "A59": "Production was scaled up at a facility.",
      "A60": "The yield was improved by the process.",
      "A61": "The procedure was documented in a lab notebook.",
      "A62": "The procedure was documented in electronic records.",
      "A63": "The protocol was standardized in the lab.",
      "A64": "The protocol was validated by quality control.",
      "G": "The project had a successful outcome."
    },
    "prover9_expressions": [
      "(approved(clinical_trial, drug_x) -> published(results, journal))",
      "(approved(clinical_trial, drug_x) -> submitted(paper, journal))",
      "(received(funding, grant_b) -> accepted(paper, journal))",
      "(positive(results, drug_x) -> successful(project, outcome))",
      "(positive(results, drug_x) | negative(results, drug_x))",
      "(negative(results, drug_x) -> successful(project, outcome))",
      "(marketed(drug_x, company) -> approved(drug_x, fda))",
      "(effective(drug_x, condition_y) -> (-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> marketed(drug_x, company)))",
      "(controversial(findings, ethics_board) -> accepted(findings, community))",
      "(controversial(findings, ethics_board) | successful(project, outcome))",
      "(contradicts(study, previous_research) -> -accepted(findings, community))",
      "(cited(paper, other_studies) -> (-(contradicts(study, previous_research) -> -accepted(findings, community)) -> requires(replication, study)))",
      "(influential(paper, field) -> cited(paper, other_studies))",
      "(influential(paper, field) | significant(paper, impact))",
      "(significant(paper, impact) -> cited(paper, other_studies))",
      "(patented(drug_x, company) -> (-successful(project, outcome) -> rejected(drug_x, fda)))",
      "(discovered(compound, researcher) -> patented(drug_x, company))",
      "(safe(compound, humans) -> tested(compound, animals))",
      "(safe(compound, humans) -> -toxic(compound, humans))",
      "(submitted(paper, journal) -> published(results, journal))",
      "(tested(compound, animals) -> -toxic(compound, humans))",
      "(licensed(technology, university) -> commercialized(technology, startup))",
      "(profitable(technology, market) | -commercialized(technology, startup))",
      "(failed(technology, market) -> -profitable(technology, market))",
      "(approved_for_trial(drug_x, ethics_board) -> approved(drug_x, fda))",
      "(enrolled(patients, trial) -> approved_for_trial(drug_x, ethics_board))",
      "(recruited(patients, hospital_a) -> (-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> enrolled(patients, trial)))",
      "(recruited(patients, hospital_a) | recruited(patients, hospital_b))",
      "(recruited(patients, hospital_b) -> (-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> enrolled(patients, trial)))",
      "(referenced(paper, textbook) -> cited(paper, other_studies))",
      "(referenced(paper, textbook) -> included(paper, meta_analysis))",
      "(requires(publication, peer_review) -> (submitted(paper, journal) -> published(results, journal)))",
      "(included(paper, meta_analysis) -> cited(paper, other_studies))",
      "(authored(paper, lead_scientist) -> (included(paper, meta_analysis) -> cited(paper, other_studies)))",
      "(authored(paper, lead_scientist) | authored(paper, team))",
      "(authored(paper, team) -> (included(paper, meta_analysis) -> cited(paper, other_studies)))",
      "(disputed(conclusions, experts) | (contradicts(study, previous_research) -> -accepted(findings, community)))",
      "(retracted(paper, journal) | (disputed(conclusions, experts) | (contradicts(study, previous_research) -> -accepted(findings, community))))",
      "(flawed(methodology, study) -> -accepted(findings, community))",
      "(valid(methodology, study) | flawed(methodology, study))",
      "(verified(results, independent_lab) -> -valid(methodology, study))",
      "(confirmed(results, replication_study) -> verified(results, independent_lab))",
      "(featured(paper, conference) -> cited(paper, other_studies))",
      "(funded(study, grant_a) -> conducted(research, university))",
      "(funded(study, grant_a) -> successful(project, outcome))",
      "(created(artwork, science_illustrator) -> featured(paper, conference))",
      "(sold(artwork, collector) -> displayed(artwork, museum))",
      "(developed(formulation, chemist) -> patented(drug_x, company))",
      "(purified(compound, process) -> synthesized(compound, lab))",
      "(optimized(synthesis, method) -> (-discovered(compound, researcher) -> purified(compound, process)))",
      "(conducted(research, university) -> analyzed(data, statistician))",
      "(conducted(research, university) -> successful(project, outcome))",
      "(improved(yield, process) -> scaled_up(production, facility))",
      "(documented(procedure, lab_notebook) -> (improved(yield, process) -> scaled_up(production, facility)))",
      "(documented(procedure, lab_notebook) | documented(procedure, electronic_records))",
      "(documented(procedure, electronic_records) -> (improved(yield, process) -> scaled_up(production, facility)))",
      "(standardized(protocol, lab) -> (documented(procedure, lab_notebook) | documented(procedure, electronic_records)))",
      "(standardized(protocol, lab) | validated(protocol, quality_control))",
      "(validated(protocol, quality_control) -> (documented(procedure, lab_notebook) | documented(procedure, electronic_records)))",
      "(analyzed(data, statistician) -> completed(study, timeline))",
      "(analyzed(data, statistician) -> successful(project, outcome))",
      "(completed(study, timeline) -> received(funding, grant_b))",
      "(completed(study, timeline) -> accepted(paper, journal))",
      "(completed(study, timeline) -> successful(project, outcome))",
      "(accepted(paper, journal) -> successful(project, outcome))",
      "(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x))",
      "(-(negative(results, drug_x) -> successful(project, outcome)) -> -inconclusive(results, drug_x))",
      "(-(contradicts(study, previous_research) -> -accepted(findings, community)) -> requires(replication, study))",
      "(-(contradicts(study, previous_research) -> -accepted(findings, community)) -> -requires(replication, study))",
      "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> approved(drug_x, fda))",
      "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> marketed(drug_x, company))",
      "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> licensed(technology, university))",
      "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> approved_for_trial(drug_x, ethics_board))",
      "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> enrolled(patients, trial))",
      "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> -approved(drug_x, fda))",
      "(-(-created(artwork, science_illustrator) -> exhibited(artwork, gallery)) -> sold(artwork, collector))",
      "(-effective(drug_x, condition_y) -> ineffective(drug_x, condition_y))",
      "(-effective(drug_x, condition_y) -> -ineffective(drug_x, condition_y))",
      "(-discovered(compound, researcher) -> toxic(compound, humans))",
      "(-discovered(compound, researcher) -> safe(compound, humans))",
      "(-discovered(compound, researcher) -> synthesized(compound, lab))",
      "(-discovered(compound, researcher) -> purified(compound, process))",
      "(-discovered(compound, researcher) -> -toxic(compound, humans))",
      "(-discovered(compound, researcher) -> -synthesized(compound, lab))",
      "(-created(artwork, science_illustrator) -> exhibited(artwork, gallery))",
      "(-developed(formulation, chemist) -> abandoned(formulation, project))",
      "(-optimized(synthesis, method) -> scaled_up(production, facility))",
      "(-optimized(synthesis, method) -> improved(yield, process))",
      "(-successful(project, outcome) -> approved(clinical_trial, drug_x))",
      "(-successful(project, outcome) -> rejected(drug_x, fda))",
      "(-successful(project, outcome) -> -rejected(drug_x, fda))",
      "effective(drug_x, condition_y)",
      "contradicts(study, previous_research)",
      "cited(paper, other_studies)",
      "patented(drug_x, company)",
      "discovered(compound, researcher)",
      "failed(technology, market)",
      "referenced(paper, textbook)",
      "requires(publication, peer_review)",
      "flawed(methodology, study)",
      "verified(results, independent_lab)",
      "confirmed(results, replication_study)",
      "featured(paper, conference)",
      "funded(study, grant_a)",
      "created(artwork, science_illustrator)",
      "developed(formulation, chemist)",
      "optimized(synthesis, method)",
      "successful(project, outcome)",
      "-approved(clinical_trial, drug_x)",
      "-controversial(findings, ethics_board)",
      "-accepted(findings, community)",
      "-published(results, journal)",
      "-licensed(technology, university)",
      "-commercialized(technology, startup)",
      "-profitable(technology, market)",
      "-disputed(conclusions, experts)",
      "-retracted(paper, journal)",
      "-valid(methodology, study)",
      "-exhibited(artwork, gallery)",
      "-sold(artwork, collector)",
      "-displayed(artwork, museum)",
      "-abandoned(formulation, project)",
      "-scaled_up(production, facility)"
    ],
    "natural_expressions": [
      "If the clinical trial for Drug X was approved, then the results were published in a journal.",
      "Provided that the clinical trial for Drug X was approved, the paper was submitted to a journal.",
      "Whenever funding is received from Grant B, the paper is accepted by the journal.",
      "In the event that the results for Drug X are positive, the project has a successful outcome.",
      "The results for Drug X are either positive or negative.",
      "Under the condition that the results for Drug X are negative, the project has a successful outcome.",
      "If Drug X is marketed by a company, then it is approved by the FDA.",
      "If Drug X is effective for Condition Y, and if it is not the case that negative results for Drug X do not lead to a successful project outcome, which implies inconclusive results for Drug X, then Drug X is marketed by a company.",
      "Provided that the findings are controversial with the ethics board, they are accepted by the community.",
      "The findings are controversial with the ethics board, or the project has a successful outcome.",
      "Whenever the study contradicts previous research, it is not the case that the findings are accepted by the community.",
      "If the paper is cited by other studies, and if the study contradicting previous research does not imply that the findings are not accepted by the community, then replication of the study is required.",
      "Given that the paper is influential in the field, it is cited by other studies.",
      "Either the paper is influential in the field, or it has significant impact.",
      "If the paper has significant impact, then it is cited by other studies.",
      "In the event that Drug X is patented by a company, and the project is not successful, then Drug X is rejected by the FDA.",
      "Whenever the compound is discovered by a researcher, Drug X is patented by a company.",
      "Under the condition that the compound is safe for humans, it is tested on animals.",
      "If the compound is safe for humans, then it is not toxic to humans.",
      "Provided that the paper is submitted to a journal, the results are published in a journal.",
      "If the compound is tested on animals, then it is not toxic to humans.",
      "Whenever the technology is licensed by a university, it is commercialized by a startup.",
      "The technology is profitable in the market, or it is not commercialized by a startup.",
      "In the case that the technology failed in the market, it is not profitable in the market.",
      "If Drug X is approved for trial by the ethics board, then it is approved by the FDA.",
      "Provided that patients are enrolled in the trial, Drug X is approved for trial by the ethics board.",
      "If patients are recruited from Hospital A, and if negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, then patients are enrolled in the trial.",
      "Patients are recruited from Hospital A, or they are recruited from Hospital B.",
      "In the event that patients are recruited from Hospital B, and negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, then patients are enrolled in the trial.",
      "Under the condition that the paper is referenced in a textbook, it is cited by other studies.",
      "If the paper is referenced in a textbook, then it is included in a meta-analysis.",
      "Whenever publication requires peer review, and the paper is submitted to a journal, then the results are published in a journal.",
      "Provided that the paper is included in a meta-analysis, it is cited by other studies.",
      "If the paper is authored by the lead scientist, and it is included in a meta-analysis, then it is cited by other studies.",
      "The paper is authored by the lead scientist, or it is authored by the team.",
      "In the case that the paper is authored by the team, and it is included in a meta-analysis, then it is cited by other studies.",
      "The conclusions are disputed by experts, or if the study contradicts previous research, then the findings are not accepted by the community.",
      "The paper is retracted by the journal, or the conclusions are disputed by experts, or if the study contradicts previous research, then the findings are not accepted by the community.",
      "If the methodology of the study is flawed, then the findings are not accepted by the community.",
      "The methodology of the study is either valid or flawed.",
      "Provided that the results are verified by an independent lab, the methodology of the study is not valid.",
      "Under the condition that the results are confirmed by a replication study, they are verified by an independent lab.",
      "If the paper is featured at a conference, then it is cited by other studies.",
      "Whenever the study is funded by Grant A, the research is conducted at a university.",
      "In the event that the study is funded by Grant A, the project has a successful outcome.",
      "If the artwork is created by a science illustrator, then the paper is featured at a conference.",
      "Provided that the artwork is sold to a collector, it is displayed in a museum.",
      "Under the condition that the formulation is developed by a chemist, Drug X is patented by a company.",
      "If the compound is purified through a process, then it is synthesized in a lab.",
      "Whenever the synthesis is optimized by a method, and the compound is not discovered by a researcher, then the compound is purified through a process.",
      "Given that the research is conducted at a university, the data are analyzed by a statistician.",
      "If the research is conducted at a university, then the project has a successful outcome.",
      "In the case that the yield is improved by the process, production is scaled up at a facility.",
      "Provided that the procedure is documented in a lab notebook, and the yield is improved by the process, then production is scaled up at a facility.",
      "The procedure is documented in a lab notebook, or it is documented in electronic records.",
      "If the procedure is documented in electronic records, and the yield is improved by the process, then production is scaled up at a facility.",
      "Whenever the protocol is standardized in the lab, the procedure is documented in a lab notebook or in electronic records.",
      "The protocol is standardized in the lab, or it is validated by quality control.",
      "Under the condition that the protocol is validated by quality control, the procedure is documented in a lab notebook or in electronic records.",
      "If the data are analyzed by a statistician, then the study is completed within the timeline.",
      "Provided that the data are analyzed by a statistician, the project has a successful outcome.",
      "In the event that the study is completed within the timeline, funding is received from Grant B.",
      "Whenever the study is completed within the timeline, the paper is accepted by the journal.",
      "If the study is completed within the timeline, then the project has a successful outcome.",
      "Given that the paper is accepted by the journal, the project has a successful outcome.",
      "If negative results for Drug X do not lead to a successful project outcome, then the results for Drug X are inconclusive.",
      "Provided that negative results for Drug X do not lead to a successful project outcome, the results for Drug X are not inconclusive.",
      "Under the condition that the study contradicting previous research does not imply that the findings are not accepted by the community, replication of the study is required.",
      "If the study contradicting previous research does not imply that the findings are not accepted by the community, then replication of the study is not required.",
      "In the case that negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, then Drug X is approved by the FDA.",
      "Whenever negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, Drug X is marketed by a company.",
      "Provided that negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, the technology is licensed by a university.",
      "If negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, then Drug X is approved for trial by the ethics board.",
      "Under the condition that negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, patients are enrolled in the trial.",
      "In the event that negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, Drug X is not approved by the FDA.",
      "If it is not the case that the artwork not being created by a science illustrator implies it is exhibited in a gallery, then the artwork is sold to a collector.",
      "Whenever Drug X is not effective for Condition Y, it is ineffective for Condition Y.",
      "Provided that Drug X is not effective for Condition Y, it is not ineffective for Condition Y.",
      "Under the condition that the compound is not discovered by a researcher, it is toxic to humans.",
      "If the compound is not discovered by a researcher, then it is safe for humans.",
      "In the case that the compound is not discovered by a researcher, it is synthesized in a lab.",
      "Provided that the compound is not discovered by a researcher, it is purified through a process.",
      "Whenever the compound is not discovered by a researcher, it is not toxic to humans.",
      "If the compound is not discovered by a researcher, then it is not synthesized in a lab.",
      "Given that the artwork is not created by a science illustrator, it is exhibited in a gallery.",
      "Under the condition that the formulation is not developed by a chemist, it is abandoned by the project.",
      "In the event that the synthesis is not optimized by a method, production is scaled up at a facility.",
      "Provided that the synthesis is not optimized by a method, the yield is improved by the process.",
      "If the project is not successful, then the clinical trial for Drug X is approved.",
      "Whenever the project is not successful, Drug X is rejected by the FDA.",
      "Under the condition that the project is not successful, Drug X is not rejected by the FDA.",
      "Drug X is effective for Condition Y.",
      "The study contradicts previous research.",
      "The paper is cited by other studies.",
      "Drug X is patented by a company.",
      "The compound is discovered by a researcher.",
      "The technology failed in the market.",
      "The paper is referenced in a textbook.",
      "Publication requires peer review.",
      "The methodology of the study is flawed.",
      "The results were verified by an independent lab.",
      "The results were confirmed by a replication study.",
      "The paper was featured at a conference.",
      "The study was funded by Grant A.",
      "The artwork was created by a science illustrator.",
      "The formulation was developed by a chemist.",
      "The synthesis was optimized by a method.",
      "The project had a successful outcome.",
      "It is not the case that the clinical trial for Drug X was approved.",
      "The findings are not controversial with the ethics board.",
      "The findings are not accepted by the community.",
      "The results were not published in a journal.",
      "The technology is not licensed by a university.",
      "The technology is not commercialized by a startup.",
      "The technology is not profitable in the market.",
      "The conclusions are not disputed by experts.",
      "The paper is not retracted by the journal.",
      "The methodology of the study is not valid.",
      "The artwork is not exhibited in a gallery.",
      "The artwork is not sold to a collector.",
      "The artwork is not displayed in a museum.",
      "The formulation is not abandoned by the project.",
      "Production is not scaled up at a facility."
    ],
    "node_mappings": {
      "(A1 → A2)": {
        "formal": "(A1 → A2)",
        "prover9": "(A1 -> A2)",
        "prover9_expression": "(approved(clinical_trial, drug_x) -> published(results, journal))",
        "natural": "If the clinical trial for Drug X was approved, then the results were published in a journal."
      },
      "(A1 → A3)": {
        "formal": "(A1 → A3)",
        "prover9": "(A1 -> A3)",
        "prover9_expression": "(approved(clinical_trial, drug_x) -> submitted(paper, journal))",
        "natural": "Provided that the clinical trial for Drug X was approved, the paper was submitted to a journal."
      },
      "(A10 → A9)": {
        "formal": "(A10 → A9)",
        "prover9": "(A10 -> A9)",
        "prover9_expression": "(received(funding, grant_b) -> accepted(paper, journal))",
        "natural": "Whenever funding is received from Grant B, the paper is accepted by the journal."
      },
      "(A11 → G)": {
        "formal": "(A11 → G)",
        "prover9": "(A11 -> G)",
        "prover9_expression": "(positive(results, drug_x) -> successful(project, outcome))",
        "natural": "In the event that the results for Drug X are positive, the project has a successful outcome."
      },
      "(A11 ∨ A12)": {
        "formal": "(A11 ∨ A12)",
        "prover9": "(A11 | A12)",
        "prover9_expression": "(positive(results, drug_x) | negative(results, drug_x))",
        "natural": "The results for Drug X are either positive or negative."
      },
      "(A12 → G)": {
        "formal": "(A12 → G)",
        "prover9": "(A12 -> G)",
        "prover9_expression": "(negative(results, drug_x) -> successful(project, outcome))",
        "natural": "Under the condition that the results for Drug X are negative, the project has a successful outcome."
      },
      "(A15 → A14)": {
        "formal": "(A15 → A14)",
        "prover9": "(A15 -> A14)",
        "prover9_expression": "(marketed(drug_x, company) -> approved(drug_x, fda))",
        "natural": "If Drug X is marketed by a company, then it is approved by the FDA."
      },
      "(A16 → (¬(¬(A12 → G) → A13) → A15))": {
        "formal": "(A16 → (¬(¬(A12 → G) → A13) → A15))",
        "prover9": "(A16 -> (-(-(A12 -> G) -> A13) -> A15))",
        "prover9_expression": "(effective(drug_x, condition_y) -> (-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> marketed(drug_x, company)))",
        "natural": "If Drug X is effective for Condition Y, and if it is not the case that negative results for Drug X do not lead to a successful project outcome, which implies inconclusive results for Drug X, then Drug X is marketed by a company."
      },
      "(A18 → A19)": {
        "formal": "(A18 → A19)",
        "prover9": "(A18 -> A19)",
        "prover9_expression": "(controversial(findings, ethics_board) -> accepted(findings, community))",
        "natural": "Provided that the findings are controversial with the ethics board, they are accepted by the community."
      },
      "(A18 ∨ G)": {
        "formal": "(A18 ∨ G)",
        "prover9": "(A18 | G)",
        "prover9_expression": "(controversial(findings, ethics_board) | successful(project, outcome))",
        "natural": "The findings are controversial with the ethics board, or the project has a successful outcome."
      },
      "(A20 → ¬A19)": {
        "formal": "(A20 → ¬A19)",
        "prover9": "(A20 -> -A19)",
        "prover9_expression": "(contradicts(study, previous_research) -> -accepted(findings, community))",
        "natural": "Whenever the study contradicts previous research, it is not the case that the findings are accepted by the community."
      },
      "(A22 → (¬(A20 → ¬A19) → A21))": {
        "formal": "(A22 → (¬(A20 → ¬A19) → A21))",
        "prover9": "(A22 -> (-(A20 -> -A19) -> A21))",
        "prover9_expression": "(cited(paper, other_studies) -> (-(contradicts(study, previous_research) -> -accepted(findings, community)) -> requires(replication, study)))",
        "natural": "If the paper is cited by other studies, and if the study contradicting previous research does not imply that the findings are not accepted by the community, then replication of the study is required."
      },
      "(A23 → A22)": {
        "formal": "(A23 → A22)",
        "prover9": "(A23 -> A22)",
        "prover9_expression": "(influential(paper, field) -> cited(paper, other_studies))",
        "natural": "Given that the paper is influential in the field, it is cited by other studies."
      },
      "(A23 ∨ A24)": {
        "formal": "(A23 ∨ A24)",
        "prover9": "(A23 | A24)",
        "prover9_expression": "(influential(paper, field) | significant(paper, impact))",
        "natural": "Either the paper is influential in the field, or it has significant impact."
      },
      "(A24 → A22)": {
        "formal": "(A24 → A22)",
        "prover9": "(A24 -> A22)",
        "prover9_expression": "(significant(paper, impact) -> cited(paper, other_studies))",
        "natural": "If the paper has significant impact, then it is cited by other studies."
      },
      "(A26 → (¬G → A25))": {
        "formal": "(A26 → (¬G → A25))",
        "prover9": "(A26 -> (-G -> A25))",
        "prover9_expression": "(patented(drug_x, company) -> (-successful(project, outcome) -> rejected(drug_x, fda)))",
        "natural": "In the event that Drug X is patented by a company, and the project is not successful, then Drug X is rejected by the FDA."
      },
      "(A27 → A26)": {
        "formal": "(A27 → A26)",
        "prover9": "(A27 -> A26)",
        "prover9_expression": "(discovered(compound, researcher) -> patented(drug_x, company))",
        "natural": "Whenever the compound is discovered by a researcher, Drug X is patented by a company."
      },
      "(A29 → A30)": {
        "formal": "(A29 → A30)",
        "prover9": "(A29 -> A30)",
        "prover9_expression": "(safe(compound, humans) -> tested(compound, animals))",
        "natural": "Under the condition that the compound is safe for humans, it is tested on animals."
      },
      "(A29 → ¬A28)": {
        "formal": "(A29 → ¬A28)",
        "prover9": "(A29 -> -A28)",
        "prover9_expression": "(safe(compound, humans) -> -toxic(compound, humans))",
        "natural": "If the compound is safe for humans, then it is not toxic to humans."
      },
      "(A3 → A2)": {
        "formal": "(A3 → A2)",
        "prover9": "(A3 -> A2)",
        "prover9_expression": "(submitted(paper, journal) -> published(results, journal))",
        "natural": "Provided that the paper is submitted to a journal, the results are published in a journal."
      },
      "(A30 → ¬A28)": {
        "formal": "(A30 → ¬A28)",
        "prover9": "(A30 -> -A28)",
        "prover9_expression": "(tested(compound, animals) -> -toxic(compound, humans))",
        "natural": "If the compound is tested on animals, then it is not toxic to humans."
      },
      "(A31 → A32)": {
        "formal": "(A31 → A32)",
        "prover9": "(A31 -> A32)",
        "prover9_expression": "(licensed(technology, university) -> commercialized(technology, startup))",
        "natural": "Whenever the technology is licensed by a university, it is commercialized by a startup."
      },
      "(A33 ∨ ¬A32)": {
        "formal": "(A33 ∨ ¬A32)",
        "prover9": "(A33 | -A32)",
        "prover9_expression": "(profitable(technology, market) | -commercialized(technology, startup))",
        "natural": "The technology is profitable in the market, or it is not commercialized by a startup."
      },
      "(A34 → ¬A33)": {
        "formal": "(A34 → ¬A33)",
        "prover9": "(A34 -> -A33)",
        "prover9_expression": "(failed(technology, market) -> -profitable(technology, market))",
        "natural": "In the case that the technology failed in the market, it is not profitable in the market."
      },
      "(A35 → A14)": {
        "formal": "(A35 → A14)",
        "prover9": "(A35 -> A14)",
        "prover9_expression": "(approved_for_trial(drug_x, ethics_board) -> approved(drug_x, fda))",
        "natural": "If Drug X is approved for trial by the ethics board, then it is approved by the FDA."
      },
      "(A36 → A35)": {
        "formal": "(A36 → A35)",
        "prover9": "(A36 -> A35)",
        "prover9_expression": "(enrolled(patients, trial) -> approved_for_trial(drug_x, ethics_board))",
        "natural": "Provided that patients are enrolled in the trial, Drug X is approved for trial by the ethics board."
      },
      "(A37 → (¬(¬(A12 → G) → A13) → A36))": {
        "formal": "(A37 → (¬(¬(A12 → G) → A13) → A36))",
        "prover9": "(A37 -> (-(-(A12 -> G) -> A13) -> A36))",
        "prover9_expression": "(recruited(patients, hospital_a) -> (-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> enrolled(patients, trial)))",
        "natural": "If patients are recruited from Hospital A, and if negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, then patients are enrolled in the trial."
      },
      "(A37 ∨ A38)": {
        "formal": "(A37 ∨ A38)",
        "prover9": "(A37 | A38)",
        "prover9_expression": "(recruited(patients, hospital_a) | recruited(patients, hospital_b))",
        "natural": "Patients are recruited from Hospital A, or they are recruited from Hospital B."
      },
      "(A38 → (¬(¬(A12 → G) → A13) → A36))": {
        "formal": "(A38 → (¬(¬(A12 → G) → A13) → A36))",
        "prover9": "(A38 -> (-(-(A12 -> G) -> A13) -> A36))",
        "prover9_expression": "(recruited(patients, hospital_b) -> (-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> enrolled(patients, trial)))",
        "natural": "In the event that patients are recruited from Hospital B, and negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, then patients are enrolled in the trial."
      },
      "(A39 → A22)": {
        "formal": "(A39 → A22)",
        "prover9": "(A39 -> A22)",
        "prover9_expression": "(referenced(paper, textbook) -> cited(paper, other_studies))",
        "natural": "Under the condition that the paper is referenced in a textbook, it is cited by other studies."
      },
      "(A39 → A40)": {
        "formal": "(A39 → A40)",
        "prover9": "(A39 -> A40)",
        "prover9_expression": "(referenced(paper, textbook) -> included(paper, meta_analysis))",
        "natural": "If the paper is referenced in a textbook, then it is included in a meta-analysis."
      },
      "(A4 → (A3 → A2))": {
        "formal": "(A4 → (A3 → A2))",
        "prover9": "(A4 -> (A3 -> A2))",
        "prover9_expression": "(requires(publication, peer_review) -> (submitted(paper, journal) -> published(results, journal)))",
        "natural": "Whenever publication requires peer review, and the paper is submitted to a journal, then the results are published in a journal."
      },
      "(A40 → A22)": {
        "formal": "(A40 → A22)",
        "prover9": "(A40 -> A22)",
        "prover9_expression": "(included(paper, meta_analysis) -> cited(paper, other_studies))",
        "natural": "Provided that the paper is included in a meta-analysis, it is cited by other studies."
      },
      "(A41 → (A40 → A22))": {
        "formal": "(A41 → (A40 → A22))",
        "prover9": "(A41 -> (A40 -> A22))",
        "prover9_expression": "(authored(paper, lead_scientist) -> (included(paper, meta_analysis) -> cited(paper, other_studies)))",
        "natural": "If the paper is authored by the lead scientist, and it is included in a meta-analysis, then it is cited by other studies."
      },
      "(A41 ∨ A42)": {
        "formal": "(A41 ∨ A42)",
        "prover9": "(A41 | A42)",
        "prover9_expression": "(authored(paper, lead_scientist) | authored(paper, team))",
        "natural": "The paper is authored by the lead scientist, or it is authored by the team."
      },
      "(A42 → (A40 → A22))": {
        "formal": "(A42 → (A40 → A22))",
        "prover9": "(A42 -> (A40 -> A22))",
        "prover9_expression": "(authored(paper, team) -> (included(paper, meta_analysis) -> cited(paper, other_studies)))",
        "natural": "In the case that the paper is authored by the team, and it is included in a meta-analysis, then it is cited by other studies."
      },
      "(A43 ∨ (A20 → ¬A19))": {
        "formal": "(A43 ∨ (A20 → ¬A19))",
        "prover9": "(A43 | (A20 -> -A19))",
        "prover9_expression": "(disputed(conclusions, experts) | (contradicts(study, previous_research) -> -accepted(findings, community)))",
        "natural": "The conclusions are disputed by experts, or if the study contradicts previous research, then the findings are not accepted by the community."
      },
      "(A44 ∨ (A43 ∨ (A20 → ¬A19)))": {
        "formal": "(A44 ∨ (A43 ∨ (A20 → ¬A19)))",
        "prover9": "(A44 | (A43 | (A20 -> -A19)))",
        "prover9_expression": "(retracted(paper, journal) | (disputed(conclusions, experts) | (contradicts(study, previous_research) -> -accepted(findings, community))))",
        "natural": "The paper is retracted by the journal, or the conclusions are disputed by experts, or if the study contradicts previous research, then the findings are not accepted by the community."
      },
      "(A45 → ¬A19)": {
        "formal": "(A45 → ¬A19)",
        "prover9": "(A45 -> -A19)",
        "prover9_expression": "(flawed(methodology, study) -> -accepted(findings, community))",
        "natural": "If the methodology of the study is flawed, then the findings are not accepted by the community."
      },
      "(A46 ∨ A45)": {
        "formal": "(A46 ∨ A45)",
        "prover9": "(A46 | A45)",
        "prover9_expression": "(valid(methodology, study) | flawed(methodology, study))",
        "natural": "The methodology of the study is either valid or flawed."
      },
      "(A47 → ¬A46)": {
        "formal": "(A47 → ¬A46)",
        "prover9": "(A47 -> -A46)",
        "prover9_expression": "(verified(results, independent_lab) -> -valid(methodology, study))",
        "natural": "Provided that the results are verified by an independent lab, the methodology of the study is not valid."
      },
      "(A48 → A47)": {
        "formal": "(A48 → A47)",
        "prover9": "(A48 -> A47)",
        "prover9_expression": "(confirmed(results, replication_study) -> verified(results, independent_lab))",
        "natural": "Under the condition that the results are confirmed by a replication study, they are verified by an independent lab."
      },
      "(A49 → A22)": {
        "formal": "(A49 → A22)",
        "prover9": "(A49 -> A22)",
        "prover9_expression": "(featured(paper, conference) -> cited(paper, other_studies))",
        "natural": "If the paper is featured at a conference, then it is cited by other studies."
      },
      "(A5 → A6)": {
        "formal": "(A5 → A6)",
        "prover9": "(A5 -> A6)",
        "prover9_expression": "(funded(study, grant_a) -> conducted(research, university))",
        "natural": "Whenever the study is funded by Grant A, the research is conducted at a university."
      },
      "(A5 → G)": {
        "formal": "(A5 → G)",
        "prover9": "(A5 -> G)",
        "prover9_expression": "(funded(study, grant_a) -> successful(project, outcome))",
        "natural": "In the event that the study is funded by Grant A, the project has a successful outcome."
      },
      "(A50 → A49)": {
        "formal": "(A50 → A49)",
        "prover9": "(A50 -> A49)",
        "prover9_expression": "(created(artwork, science_illustrator) -> featured(paper, conference))",
        "natural": "If the artwork is created by a science illustrator, then the paper is featured at a conference."
      },
      "(A52 → A53)": {
        "formal": "(A52 → A53)",
        "prover9": "(A52 -> A53)",
        "prover9_expression": "(sold(artwork, collector) -> displayed(artwork, museum))",
        "natural": "Provided that the artwork is sold to a collector, it is displayed in a museum."
      },
      "(A54 → A26)": {
        "formal": "(A54 → A26)",
        "prover9": "(A54 -> A26)",
        "prover9_expression": "(developed(formulation, chemist) -> patented(drug_x, company))",
        "natural": "Under the condition that the formulation is developed by a chemist, Drug X is patented by a company."
      },
      "(A57 → A56)": {
        "formal": "(A57 → A56)",
        "prover9": "(A57 -> A56)",
        "prover9_expression": "(purified(compound, process) -> synthesized(compound, lab))",
        "natural": "If the compound is purified through a process, then it is synthesized in a lab."
      },
      "(A58 → (¬A27 → A57))": {
        "formal": "(A58 → (¬A27 → A57))",
        "prover9": "(A58 -> (-A27 -> A57))",
        "prover9_expression": "(optimized(synthesis, method) -> (-discovered(compound, researcher) -> purified(compound, process)))",
        "natural": "Whenever the synthesis is optimized by a method, and the compound is not discovered by a researcher, then the compound is purified through a process."
      },
      "(A6 → A7)": {
        "formal": "(A6 → A7)",
        "prover9": "(A6 -> A7)",
        "prover9_expression": "(conducted(research, university) -> analyzed(data, statistician))",
        "natural": "Given that the research is conducted at a university, the data are analyzed by a statistician."
      },
      "(A6 → G)": {
        "formal": "(A6 → G)",
        "prover9": "(A6 -> G)",
        "prover9_expression": "(conducted(research, university) -> successful(project, outcome))",
        "natural": "If the research is conducted at a university, then the project has a successful outcome."
      },
      "(A60 → A59)": {
        "formal": "(A60 → A59)",
        "prover9": "(A60 -> A59)",
        "prover9_expression": "(improved(yield, process) -> scaled_up(production, facility))",
        "natural": "In the case that the yield is improved by the process, production is scaled up at a facility."
      },
      "(A61 → (A60 → A59))": {
        "formal": "(A61 → (A60 → A59))",
        "prover9": "(A61 -> (A60 -> A59))",
        "prover9_expression": "(documented(procedure, lab_notebook) -> (improved(yield, process) -> scaled_up(production, facility)))",
        "natural": "Provided that the procedure is documented in a lab notebook, and the yield is improved by the process, then production is scaled up at a facility."
      },
      "(A61 ∨ A62)": {
        "formal": "(A61 ∨ A62)",
        "prover9": "(A61 | A62)",
        "prover9_expression": "(documented(procedure, lab_notebook) | documented(procedure, electronic_records))",
        "natural": "The procedure is documented in a lab notebook, or it is documented in electronic records."
      },
      "(A62 → (A60 → A59))": {
        "formal": "(A62 → (A60 → A59))",
        "prover9": "(A62 -> (A60 -> A59))",
        "prover9_expression": "(documented(procedure, electronic_records) -> (improved(yield, process) -> scaled_up(production, facility)))",
        "natural": "If the procedure is documented in electronic records, and the yield is improved by the process, then production is scaled up at a facility."
      },
      "(A63 → (A61 ∨ A62))": {
        "formal": "(A63 → (A61 ∨ A62))",
        "prover9": "(A63 -> (A61 | A62))",
        "prover9_expression": "(standardized(protocol, lab) -> (documented(procedure, lab_notebook) | documented(procedure, electronic_records)))",
        "natural": "Whenever the protocol is standardized in the lab, the procedure is documented in a lab notebook or in electronic records."
      },
      "(A63 ∨ A64)": {
        "formal": "(A63 ∨ A64)",
        "prover9": "(A63 | A64)",
        "prover9_expression": "(standardized(protocol, lab) | validated(protocol, quality_control))",
        "natural": "The protocol is standardized in the lab, or it is validated by quality control."
      },
      "(A64 → (A61 ∨ A62))": {
        "formal": "(A64 → (A61 ∨ A62))",
        "prover9": "(A64 -> (A61 | A62))",
        "prover9_expression": "(validated(protocol, quality_control) -> (documented(procedure, lab_notebook) | documented(procedure, electronic_records)))",
        "natural": "Under the condition that the protocol is validated by quality control, the procedure is documented in a lab notebook or in electronic records."
      },
      "(A7 → A8)": {
        "formal": "(A7 → A8)",
        "prover9": "(A7 -> A8)",
        "prover9_expression": "(analyzed(data, statistician) -> completed(study, timeline))",
        "natural": "If the data are analyzed by a statistician, then the study is completed within the timeline."
      },
      "(A7 → G)": {
        "formal": "(A7 → G)",
        "prover9": "(A7 -> G)",
        "prover9_expression": "(analyzed(data, statistician) -> successful(project, outcome))",
        "natural": "Provided that the data are analyzed by a statistician, the project has a successful outcome."
      },
      "(A8 → A10)": {
        "formal": "(A8 → A10)",
        "prover9": "(A8 -> A10)",
        "prover9_expression": "(completed(study, timeline) -> received(funding, grant_b))",
        "natural": "In the event that the study is completed within the timeline, funding is received from Grant B."
      },
      "(A8 → A9)": {
        "formal": "(A8 → A9)",
        "prover9": "(A8 -> A9)",
        "prover9_expression": "(completed(study, timeline) -> accepted(paper, journal))",
        "natural": "Whenever the study is completed within the timeline, the paper is accepted by the journal."
      },
      "(A8 → G)": {
        "formal": "(A8 → G)",
        "prover9": "(A8 -> G)",
        "prover9_expression": "(completed(study, timeline) -> successful(project, outcome))",
        "natural": "If the study is completed within the timeline, then the project has a successful outcome."
      },
      "(A9 → G)": {
        "formal": "(A9 → G)",
        "prover9": "(A9 -> G)",
        "prover9_expression": "(accepted(paper, journal) -> successful(project, outcome))",
        "natural": "Given that the paper is accepted by the journal, the project has a successful outcome."
      },
      "(¬(A12 → G) → A13)": {
        "formal": "(¬(A12 → G) → A13)",
        "prover9": "(-(A12 -> G) -> A13)",
        "prover9_expression": "(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x))",
        "natural": "If negative results for Drug X do not lead to a successful project outcome, then the results for Drug X are inconclusive."
      },
      "(¬(A12 → G) → ¬A13)": {
        "formal": "(¬(A12 → G) → ¬A13)",
        "prover9": "(-(A12 -> G) -> -A13)",
        "prover9_expression": "(-(negative(results, drug_x) -> successful(project, outcome)) -> -inconclusive(results, drug_x))",
        "natural": "Provided that negative results for Drug X do not lead to a successful project outcome, the results for Drug X are not inconclusive."
      },
      "(¬(A20 → ¬A19) → A21)": {
        "formal": "(¬(A20 → ¬A19) → A21)",
        "prover9": "(-(A20 -> -A19) -> A21)",
        "prover9_expression": "(-(contradicts(study, previous_research) -> -accepted(findings, community)) -> requires(replication, study))",
        "natural": "Under the condition that the study contradicting previous research does not imply that the findings are not accepted by the community, replication of the study is required."
      },
      "(¬(A20 → ¬A19) → ¬A21)": {
        "formal": "(¬(A20 → ¬A19) → ¬A21)",
        "prover9": "(-(A20 -> -A19) -> -A21)",
        "prover9_expression": "(-(contradicts(study, previous_research) -> -accepted(findings, community)) -> -requires(replication, study))",
        "natural": "If the study contradicting previous research does not imply that the findings are not accepted by the community, then replication of the study is not required."
      },
      "(¬(¬(A12 → G) → A13) → A14)": {
        "formal": "(¬(¬(A12 → G) → A13) → A14)",
        "prover9": "(-(-(A12 -> G) -> A13) -> A14)",
        "prover9_expression": "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> approved(drug_x, fda))",
        "natural": "In the case that negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, then Drug X is approved by the FDA."
      },
      "(¬(¬(A12 → G) → A13) → A15)": {
        "formal": "(¬(¬(A12 → G) → A13) → A15)",
        "prover9": "(-(-(A12 -> G) -> A13) -> A15)",
        "prover9_expression": "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> marketed(drug_x, company))",
        "natural": "Whenever negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, Drug X is marketed by a company."
      },
      "(¬(¬(A12 → G) → A13) → A31)": {
        "formal": "(¬(¬(A12 → G) → A13) → A31)",
        "prover9": "(-(-(A12 -> G) -> A13) -> A31)",
        "prover9_expression": "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> licensed(technology, university))",
        "natural": "Provided that negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, the technology is licensed by a university."
      },
      "(¬(¬(A12 → G) → A13) → A35)": {
        "formal": "(¬(¬(A12 → G) → A13) → A35)",
        "prover9": "(-(-(A12 -> G) -> A13) -> A35)",
        "prover9_expression": "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> approved_for_trial(drug_x, ethics_board))",
        "natural": "If negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, then Drug X is approved for trial by the ethics board."
      },
      "(¬(¬(A12 → G) → A13) → A36)": {
        "formal": "(¬(¬(A12 → G) → A13) → A36)",
        "prover9": "(-(-(A12 -> G) -> A13) -> A36)",
        "prover9_expression": "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> enrolled(patients, trial))",
        "natural": "Under the condition that negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, patients are enrolled in the trial."
      },
      "(¬(¬(A12 → G) → A13) → ¬A14)": {
        "formal": "(¬(¬(A12 → G) → A13) → ¬A14)",
        "prover9": "(-(-(A12 -> G) -> A13) -> -A14)",
        "prover9_expression": "(-(-(negative(results, drug_x) -> successful(project, outcome)) -> inconclusive(results, drug_x)) -> -approved(drug_x, fda))",
        "natural": "In the event that negative results for Drug X not leading to a successful project outcome does not imply inconclusive results for Drug X, Drug X is not approved by the FDA."
      },
      "(¬(¬A50 → A51) → A52)": {
        "formal": "(¬(¬A50 → A51) → A52)",
        "prover9": "(-(-A50 -> A51) -> A52)",
        "prover9_expression": "(-(-created(artwork, science_illustrator) -> exhibited(artwork, gallery)) -> sold(artwork, collector))",
        "natural": "If it is not the case that the artwork not being created by a science illustrator implies it is exhibited in a gallery, then the artwork is sold to a collector."
      },
      "(¬A16 → A17)": {
        "formal": "(¬A16 → A17)",
        "prover9": "(-A16 -> A17)",
        "prover9_expression": "(-effective(drug_x, condition_y) -> ineffective(drug_x, condition_y))",
        "natural": "Whenever Drug X is not effective for Condition Y, it is ineffective for Condition Y."
      },
      "(¬A16 → ¬A17)": {
        "formal": "(¬A16 → ¬A17)",
        "prover9": "(-A16 -> -A17)",
        "prover9_expression": "(-effective(drug_x, condition_y) -> -ineffective(drug_x, condition_y))",
        "natural": "Provided that Drug X is not effective for Condition Y, it is not ineffective for Condition Y."
      },
      "(¬A27 → A28)": {
        "formal": "(¬A27 → A28)",
        "prover9": "(-A27 -> A28)",
        "prover9_expression": "(-discovered(compound, researcher) -> toxic(compound, humans))",
        "natural": "Under the condition that the compound is not discovered by a researcher, it is toxic to humans."
      },
      "(¬A27 → A29)": {
        "formal": "(¬A27 → A29)",
        "prover9": "(-A27 -> A29)",
        "prover9_expression": "(-discovered(compound, researcher) -> safe(compound, humans))",
        "natural": "If the compound is not discovered by a researcher, then it is safe for humans."
      },
      "(¬A27 → A56)": {
        "formal": "(¬A27 → A56)",
        "prover9": "(-A27 -> A56)",
        "prover9_expression": "(-discovered(compound, researcher) -> synthesized(compound, lab))",
        "natural": "In the case that the compound is not discovered by a researcher, it is synthesized in a lab."
      },
      "(¬A27 → A57)": {
        "formal": "(¬A27 → A57)",
        "prover9": "(-A27 -> A57)",
        "prover9_expression": "(-discovered(compound, researcher) -> purified(compound, process))",
        "natural": "Provided that the compound is not discovered by a researcher, it is purified through a process."
      },
      "(¬A27 → ¬A28)": {
        "formal": "(¬A27 → ¬A28)",
        "prover9": "(-A27 -> -A28)",
        "prover9_expression": "(-discovered(compound, researcher) -> -toxic(compound, humans))",
        "natural": "Whenever the compound is not discovered by a researcher, it is not toxic to humans."
      },
      "(¬A27 → ¬A56)": {
        "formal": "(¬A27 → ¬A56)",
        "prover9": "(-A27 -> -A56)",
        "prover9_expression": "(-discovered(compound, researcher) -> -synthesized(compound, lab))",
        "natural": "If the compound is not discovered by a researcher, then it is not synthesized in a lab."
      },
      "(¬A50 → A51)": {
        "formal": "(¬A50 → A51)",
        "prover9": "(-A50 -> A51)",
        "prover9_expression": "(-created(artwork, science_illustrator) -> exhibited(artwork, gallery))",
        "natural": "Given that the artwork is not created by a science illustrator, it is exhibited in a gallery."
      },
      "(¬A54 → A55)": {
        "formal": "(¬A54 → A55)",
        "prover9": "(-A54 -> A55)",
        "prover9_expression": "(-developed(formulation, chemist) -> abandoned(formulation, project))",
        "natural": "Under the condition that the formulation is not developed by a chemist, it is abandoned by the project."
      },
      "(¬A58 → A59)": {
        "formal": "(¬A58 → A59)",
        "prover9": "(-A58 -> A59)",
        "prover9_expression": "(-optimized(synthesis, method) -> scaled_up(production, facility))",
        "natural": "In the event that the synthesis is not optimized by a method, production is scaled up at a facility."
      },
      "(¬A58 → A60)": {
        "formal": "(¬A58 → A60)",
        "prover9": "(-A58 -> A60)",
        "prover9_expression": "(-optimized(synthesis, method) -> improved(yield, process))",
        "natural": "Provided that the synthesis is not optimized by a method, the yield is improved by the process."
      },
      "(¬G → A1)": {
        "formal": "(¬G → A1)",
        "prover9": "(-G -> A1)",
        "prover9_expression": "(-successful(project, outcome) -> approved(clinical_trial, drug_x))",
        "natural": "If the project is not successful, then the clinical trial for Drug X is approved."
      },
      "(¬G → A25)": {
        "formal": "(¬G → A25)",
        "prover9": "(-G -> A25)",
        "prover9_expression": "(-successful(project, outcome) -> rejected(drug_x, fda))",
        "natural": "Whenever the project is not successful, Drug X is rejected by the FDA."
      },
      "(¬G → ¬A25)": {
        "formal": "(¬G → ¬A25)",
        "prover9": "(-G -> -A25)",
        "prover9_expression": "(-successful(project, outcome) -> -rejected(drug_x, fda))",
        "natural": "Under the condition that the project is not successful, Drug X is not rejected by the FDA."
      },
      "A16": {
        "formal": "A16",
        "prover9": "A16",
        "prover9_expression": "effective(drug_x, condition_y)",
        "natural": "Drug X is effective for Condition Y."
      },
      "A20": {
        "formal": "A20",
        "prover9": "A20",
        "prover9_expression": "contradicts(study, previous_research)",
        "natural": "The study contradicts previous research."
      },
      "A22": {
        "formal": "A22",
        "prover9": "A22",
        "prover9_expression": "cited(paper, other_studies)",
        "natural": "The paper is cited by other studies."
      },
      "A26": {
        "formal": "A26",
        "prover9": "A26",
        "prover9_expression": "patented(drug_x, company)",
        "natural": "Drug X is patented by a company."
      },
      "A27": {
        "formal": "A27",
        "prover9": "A27",
        "prover9_expression": "discovered(compound, researcher)",
        "natural": "The compound is discovered by a researcher."
      },
      "A34": {
        "formal": "A34",
        "prover9": "A34",
        "prover9_expression": "failed(technology, market)",
        "natural": "The technology failed in the market."
      },
      "A39": {
        "formal": "A39",
        "prover9": "A39",
        "prover9_expression": "referenced(paper, textbook)",
        "natural": "The paper is referenced in a textbook."
      },
      "A4": {
        "formal": "A4",
        "prover9": "A4",
        "prover9_expression": "requires(publication, peer_review)",
        "natural": "Publication requires peer review."
      },
      "A45": {
        "formal": "A45",
        "prover9": "A45",
        "prover9_expression": "flawed(methodology, study)",
        "natural": "The methodology of the study is flawed."
      },
      "A47": {
        "formal": "A47",
        "prover9": "A47",
        "prover9_expression": "verified(results, independent_lab)",
        "natural": "The results were verified by an independent lab."
      },
      "A48": {
        "formal": "A48",
        "prover9": "A48",
        "prover9_expression": "confirmed(results, replication_study)",
        "natural": "The results were confirmed by a replication study."
      },
      "A49": {
        "formal": "A49",
        "prover9": "A49",
        "prover9_expression": "featured(paper, conference)",
        "natural": "The paper was featured at a conference."
      },
      "A5": {
        "formal": "A5",
        "prover9": "A5",
        "prover9_expression": "funded(study, grant_a)",
        "natural": "The study was funded by Grant A."
      },
      "A50": {
        "formal": "A50",
        "prover9": "A50",
        "prover9_expression": "created(artwork, science_illustrator)",
        "natural": "The artwork was created by a science illustrator."
      },
      "A54": {
        "formal": "A54",
        "prover9": "A54",
        "prover9_expression": "developed(formulation, chemist)",
        "natural": "The formulation was developed by a chemist."
      },
      "A58": {
        "formal": "A58",
        "prover9": "A58",
        "prover9_expression": "optimized(synthesis, method)",
        "natural": "The synthesis was optimized by a method."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "successful(project, outcome)",
        "natural": "The project had a successful outcome."
      },
      "¬A1": {
        "formal": "¬A1",
        "prover9": "-A1",
        "prover9_expression": "-approved(clinical_trial, drug_x)",
        "natural": "It is not the case that the clinical trial for Drug X was approved."
      },
      "¬A18": {
        "formal": "¬A18",
        "prover9": "-A18",
        "prover9_expression": "-controversial(findings, ethics_board)",
        "natural": "The findings are not controversial with the ethics board."
      },
      "¬A19": {
        "formal": "¬A19",
        "prover9": "-A19",
        "prover9_expression": "-accepted(findings, community)",
        "natural": "The findings are not accepted by the community."
      },
      "¬A2": {
        "formal": "¬A2",
        "prover9": "-A2",
        "prover9_expression": "-published(results, journal)",
        "natural": "The results were not published in a journal."
      },
      "¬A31": {
        "formal": "¬A31",
        "prover9": "-A31",
        "prover9_expression": "-licensed(technology, university)",
        "natural": "The technology is not licensed by a university."
      },
      "¬A32": {
        "formal": "¬A32",
        "prover9": "-A32",
        "prover9_expression": "-commercialized(technology, startup)",
        "natural": "The technology is not commercialized by a startup."
      },
      "¬A33": {
        "formal": "¬A33",
        "prover9": "-A33",
        "prover9_expression": "-profitable(technology, market)",
        "natural": "The technology is not profitable in the market."
      },
      "¬A43": {
        "formal": "¬A43",
        "prover9": "-A43",
        "prover9_expression": "-disputed(conclusions, experts)",
        "natural": "The conclusions are not disputed by experts."
      },
      "¬A44": {
        "formal": "¬A44",
        "prover9": "-A44",
        "prover9_expression": "-retracted(paper, journal)",
        "natural": "The paper is not retracted by the journal."
      },
      "¬A46": {
        "formal": "¬A46",
        "prover9": "-A46",
        "prover9_expression": "-valid(methodology, study)",
        "natural": "The methodology of the study is not valid."
      },
      "¬A51": {
        "formal": "¬A51",
        "prover9": "-A51",
        "prover9_expression": "-exhibited(artwork, gallery)",
        "natural": "The artwork is not exhibited in a gallery."
      },
      "¬A52": {
        "formal": "¬A52",
        "prover9": "-A52",
        "prover9_expression": "-sold(artwork, collector)",
        "natural": "The artwork is not sold to a collector."
      },
      "¬A53": {
        "formal": "¬A53",
        "prover9": "-A53",
        "prover9_expression": "-displayed(artwork, museum)",
        "natural": "The artwork is not displayed in a museum."
      },
      "¬A55": {
        "formal": "¬A55",
        "prover9": "-A55",
        "prover9_expression": "-abandoned(formulation, project)",
        "natural": "The formulation is not abandoned by the project."
      },
      "¬A59": {
        "formal": "¬A59",
        "prover9": "-A59",
        "prover9_expression": "-scaled_up(production, facility)",
        "natural": "Production is not scaled up at a facility."
      }
    }
  }
}